Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- TXG -25.8% (guides Q3 revs below consensus), ETWO -21.8%, INDV -17.1% (Q3 guidance), DAL -5.3%, APLD -2.7%, BKE -1.4% (Sep comps)
Other news:
- IMTX -14.1% (announces updated phase 1b clinical data on ACTengine IMA203 TCR-T targeting PRAME in melanoma patients and provides update on upcoming SUPRAME Phase 3 Trial; announces proposed $150 mln public offering)
- APAM -4.2% (reports Sept AUM)
- BIPC -1.5% (Brookfield Infrastructure (BIP) announces reorganization of Brookfield Infrastructure Corporation)
- PFE -1.3% (issues statement from Former Pfizer CEO Ian Read and Former Pfizer CFO Frank D'Amelio regarding Starboard Value)
- BNS -0.8% (files $50 bln mixed shelf securities offering)